BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29114388)

  • 1. Epistatic interactions between mutations of TACI (
    Ameratunga R; Koopmans W; Woon ST; Leung E; Lehnert K; Slade CA; Tempany JC; Enders A; Steele R; Browett P; Hodgkin PD; Bryant VL
    Clin Transl Immunology; 2017 Oct; 6(10):e159. PubMed ID: 29114388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TACI is mutant in common variable immunodeficiency and IgA deficiency.
    Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
    Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Karaca NE; Severcan EU; Guven B; Azarsiz E; Aksu G; Kutukculer N
    Avicenna J Med Biotechnol; 2018; 10(3):192-195. PubMed ID: 30090215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
    Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
    J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.
    Pulvirenti F; Zuntini R; Milito C; Specchia F; Spadaro G; Danieli MG; Pession A; Quinti I; Ferrari S
    J Immunol Res; 2016; 2016():8390356. PubMed ID: 27123465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
    Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
    Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TACI mutation in common variable immunodeficiency and IgA deficiency.
    Rachid R; Castigli E; Geha RS; Bonilla FA
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI.
    Ramirez N; Posadas-Cantera S; Langer N; de Oteyza ACG; Proietti M; Keller B; Zhao F; Gernedl V; Pecoraro M; Eibel H; Warnatz K; Ballestar E; Geiger R; Bossen C; Grimbacher B
    Front Immunol; 2022; 13():938240. PubMed ID: 36072607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
    Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
    J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
    Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
    Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
    Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
    Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
    Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus.
    Salzer U; Birmelin J; Bacchelli C; Witte T; Buchegger-Podbielski U; Buckridge S; Rzepka R; Gaspar HB; Thrasher AJ; Schmidt RE; Melchers I; Grimbacher B
    J Clin Immunol; 2007 Jul; 27(4):372-7. PubMed ID: 17464555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACI deficiency - a complex system out of balance.
    Salzer U; Grimbacher B
    Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.